PCV68 COST-EFFECTIVENESS OF RAISING HDL-CWITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH PERSISTENT DYSLIPIDEMIA IN AUSTRIAN, SWEDISH AND NORWEGIAN SETTINGS

Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67479-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67479-7/fulltext
Section Title :
Section Order : 43
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67479-7&doi=10.1016/S1098-3015(10)67479-7
HEOR Topics :
Tags :
Regions :